QuidelOrtho Corporation
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 1.70B | 3.27B | 3.00B | 2.78B | 2.73B | -1.9% | |
| Cost of Revenue | (420.30M) | (1.33B) | (1.50B) | (1.50B) | (1.46B) | -2.7% | |
Gross Profit | 1.28B | 1.94B | 1.50B | 1.29B | 1.27B | -1.0% | |
| Operating Expenses | |||||||
| Research & Development | (95.70M) | (187.90M) | (246.80M) | (218.70M) | (186.20M) | -14.9% | |
| Selling, General & Administrative | (239.60M) | (621.00M) | (763.20M) | (766.80M) | (746.30M) | -2.7% | |
| Depreciation & Amortization | (52.70M) | (283.60M) | (457.20M) | (453.40M) | (442.00M) | -2.5% | |
Operating Income (EBIT) | 906.00M | 843.70M | 139.10M | -1.96B | -919.20M | -53.1% | |
| Non-Operating Items | |||||||
| Interest Income | 300.00K | 1.30M | 2.20M | — | — | — | |
| Interest Expense | (700.00K) | (74.50M) | (178.90M) | (188.30M) | (177.60M) | -5.7% | |
| Other Income/Expenses (Net) | -5.70M | -107.80M | -168.20M | -170.60M | -188.50M | 10.5% | |
Income Before Tax | 900.30M | 735.90M | -29.10M | -2.13B | -1.11B | -48.0% | |
| Income Tax Expense | (196.10M) | (187.20M) | (19.00M) | (79.50M) | (24.10M) | -130.3% | |
Net Income | 704.20M | 548.70M | -10.10M | -2.05B | -1.13B | -44.8% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $17 | $10 | $-0 | $-31 | $-17 | -45.4% | |
| Weighted Avg Shares Outstanding | 42.08M | 56.80M | 66.80M | 67.20M | 67.80M | 0.9% | |
| Weighted Avg Shares Outstanding (Diluted) | 42.87M | 57.40M | 66.80M | 67.20M | 67.80M | 0.9% | |
EBITDA | 953.30M | 1.09B | 607.00M | -1.49B | -488.10M | -67.2% |
Explore QDEL
QDEL in the Healthcare
Small Cap